Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken

Wo zu kaufen (1) Eigenschaften

Gesponsert

Biosimilars als Arzneimittel. Ein Überblick über die Chancen und Risiken

Medimops DE

15.95 EUR

Preis aktualisiert am: 19-06-2026 20:08:24

Siehe Produktangebot

Allgemein

Marke

Jenny Cremer

Eigenschaften

Ähnliche Produkte

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Produkt anzeigen

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Produkt anzeigen

Strategy to Commercialize Biosimilar in European Union

Strategy to Commercialize Biosimilar in European Union

Produkt anzeigen

Introduction to Biologic and Biosimilar Product Development and Analysis

Introduction to Biologic and Biosimilar Product Development and Analysis

Produkt anzeigen

Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and ... BIOLOGIC AND THE BIOSIMILAR INTO ACCOUNT

Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and ... BIOLOGIC AND THE BIOSIMILAR INTO ACCOUNT

Produkt anzeigen

Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account

Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account

Produkt anzeigen